| abstract |
The pharmaceutical composition for transdermal administration comprises a) optionally a polymeric release matrix capable of forming a flexible film upon drying selected from the group consisting of cellulose polymers and copolymers and vinylpyrrolidone / vinyl acetate copolymers, b) active agent, c) transcutaneous absorption promoter of the active agent, d) a non-aqueous solvent capable of dissolving the release matrix, the active agent and the transcutaneous absorption promoter of the active agent, and capable of being rapidly removed by evaporation on contact with the skin. |